Kineta Inc. buy melinda
Start price
12.03.18
/
50%
€790.51
Target price
19.03.18
€1,515.4
Performance (%)
15.02%
End price
19.03.18
€909.22
Summary
This prediction ended on 19.03.18 with a price of €909.22. The prediction had a final performance of 15.02%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kineta Inc. | - | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by melinda for this prediction
In the thread Proteostasis Therapeutics Inc diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 14/03 | 15.00 Uhr Präsentation
$ ITP gibt FDA - Bezeichnung revolutionäre Behandlung für ITP-428 in kystiqu Fibrose
(Vom Mitglied beendet)